The US government is working not only to expedite development of a new vaccine targeted at SARS-CoV-2, the novel coronavirus at the heart of the outbreak that began in China in late 2019, but also taking steps to develop a universal vaccine directed across coronaviruses.
At a 13 February meeting, the National Vaccine Advisory Committee heard several presentations on efforts by federal agencies and academic...







